Vaxess Technologies, Inc. is a pioneering life sciences company focused on the development of innovative vaccine and therapeutic delivery technologies. Their flagship product, the MIMIX™ platform, is a cutting-edge transdermal patch system that aims to make vaccines and therapeutics more effective and accessible, particularly in challenging environments.
Company Values
Vaxess sets itself apart through its needle-free delivery method and its ability to eliminate the need for cold storage, which is crucial for vaccine distribution in resource-limited settings.